Just A Few Early Guesses -- At Merck's Q2 2013 Results

Updated: I'll concur with the average Street estimates and expect EPS of $0.83, on revenue of $11.2 billion, come Tuesday morning.

I'll refine this a bit (see preliminary graphic at right) -- with some actual EPS and global sales revenue guesses at some point --  but since Pfizer's Q2 2013 results press release is also on Tuesday morning, I can't really cheat by looking at what Pfizer turns in.

Yes, Merck will be reporting at nearly the same time.

In any event, see the "Kentucky windage" I've thus far gleaned -- solely from reading J&J's Q2 release a few weeks back.

Most Wall Street analysts expect an "in-line" quarter, when Merck reports on Tuesday morning. Do tune in.